Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Charles Conway currently holds 22,135 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Charles Conway has been a net seller of BHVN stock. They have purchased $68.0K and sold $288.6K worth of shares.
Charles Conway's most recent insider trade was on Oct 3, 2022, when they sold 22,362 shares at $148.50 per share.
Charles Conway serves as Executive at Biohaven Pharmaceutical Holding Co Ltd. (BHVN). They have executed 14 insider transactions totaling $356.6K over their tenure at the company.
Charles Conway holds the position of Executive at Biohaven Pharmaceutical Holding Co Ltd., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 9 years and currently hold a stake valued at $0.
Charles Conway has shown a selling trading pattern, with $68.0K in total purchases and $288.6K in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Charles Conway was on Oct 3, 2022, when they sold $3.3M worth of BHVN shares. This transaction involved 22,362 shares at $148.50 per share.
Charles Conway currently owns 22,135 shares of Biohaven Pharmaceutical Holding Co Ltd. (BHVN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Charles Conway's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Charles Conway has 14 Form 4 filings on record as an insider at Biohaven Pharmaceutical Holding Co Ltd..
Set alerts for Charles Conway and 40,000+ other insiders.